SEC Form 4 · accession 0000920465-17-000037
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George F Tidmarsh
Officer — President, CEO & Secretary · Director
Period of report
Mar 2, 2017
Accepted (ET)
Mar 6, 2017 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2017 | P | 2,000 | $34.1773 | A | 1,353,086 | D | |
| Common Stock | Mar 3, 2017 | P | 1,000 | $34.15 | A | 1,354,086 | D |
Table II — derivative securities
No Table II lines on this filing.